v3.26.1
Liquidity (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 31, 2026
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Proceeds from the exercise of common stock warrants       $ 82,918 $ 4,712  
Exercised (in shares)       48,800,000    
Exercise price (in dollars per share)   $ 1.70   $ 1.70    
Cash and cash equivalents   $ 138,343   $ 138,343   $ 71,793
Restricted cash and cash equivalents   100   100   100
Accumulated deficit   293,000   293,000   $ 274,988
Net loss   $ 9,605 $ 6,601 18,012 12,414  
Net cash used in operating activities       $ 16,434 $ 16,400  
At-The-Market Equity Offering Program (2026 ATM)            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Net proceeds of common stock $ 150,000          
Number of shares of common stock sold (in shares)       0